SUTENT *
- Sunitinib Malate - @ - Protein -Tyrosine Kinase Inhibitors - Antineoplastic Agents
Compositions:
Sunitinib malate 12.5mg/25mg/50mg capsules, ,
List of Related Indications:
Sunitinib malate 12.5mg/25mg/50mg capsules, ,
- Advanced renal cell carcinoma
| Strength | Rate | Packing Style |
|---|---|---|
| 12.5mg./25mg/50mg | 0.00 | in 28s pack |
Manufacturer Details